Cumberland Pharmaceuticals Inc. Payments of Stock Issuance Costs
Cumberland Pharmaceuticals Inc. (CPIX) reported Payments of Stock Issuance Costs of $0 for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-11.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfStockIssuanceCosts · last filed 2022-03-11
- Cumberland Pharmaceuticals Inc. payments of stock issuance costs for the quarter ending 2020-12-31 was $135.41K.
- Cumberland Pharmaceuticals Inc. payments of stock issuance costs for the quarter ending 2019-12-31 was -$52.50K, a 138.83% decline year-over-year.
- Cumberland Pharmaceuticals Inc. payments of stock issuance costs for the quarter ending 2019-09-30 was $52.50K.
- Cumberland Pharmaceuticals Inc. payments of stock issuance costs for the quarter ending 2019-06-30 was $0.00.
- Cumberland Pharmaceuticals Inc. payments of stock issuance costs for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- Cumberland Pharmaceuticals Inc. payments of stock issuance costs for fiscal 2020 was $135.41K.
- Cumberland Pharmaceuticals Inc. payments of stock issuance costs for fiscal 2019 was $0.00, a 100.00% decline from fiscal 2018.
- Cumberland Pharmaceuticals Inc. payments of stock issuance costs for fiscal 2018 was $383.31K.
| Period end | Payments of Stock Issuance Costs 3 month | Payments of Stock Issuance Costs 6 month | Payments of Stock Issuance Costs 9 month | Payments of Stock Issuance Costs 9 month as first filed | Payments of Stock Issuance Costs 12 month |
|---|---|---|---|---|---|
| 2021-12-31 | $0.00 10-K · filed 2022-03-11 | ||||
| 2020-12-31 | $135.41K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $135.41K 10-K · filed 2022-03-11 | |||
| 2020-09-30 | $0.00 10-Q · filed 2020-11-13 | ||||
| 2019-12-31 | -$52.50K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $0.00 derived: sum of 2 quarters · filed 2022-03-11 | $0.00 derived: sum of 3 quarters · filed 2022-03-11 | $0.00 10-K · filed 2022-03-11 | |
| 2019-09-30 | $52.50K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | $52.50K derived: sum of 2 quarters · filed 2020-11-13 | $52.50K 10-Q · filed 2020-11-13 | $0.00 10-Q · filed 2019-11-13 | $187.70K derived: sum of 4 quarters · filed 2021-03-12 |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $0.00 10-Q · filed 2019-08-14 | $135.20K derived: sum of 3 quarters · filed 2021-03-12 | $135.20K derived: sum of 4 quarters · filed 2021-03-12 | |
| 2019-03-31 | $0.00 10-Q · filed 2019-05-15 | $135.20K derived: sum of 2 quarters · filed 2021-03-12 | $135.20K derived: sum of 3 quarters · filed 2021-03-12 | $135.20K derived: sum of 4 quarters · filed 2021-03-12 | |
| 2018-12-31 | $135.20K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $135.20K derived: sum of 2 quarters · filed 2021-03-12 | $135.20K derived: sum of 3 quarters · filed 2021-03-12 | $383.31K 10-K · filed 2021-03-12 | |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | $0.00 derived: sum of 2 quarters · filed 2019-11-13 | $248.11K 10-Q · filed 2019-11-13 | $276.06K derived: sum of 4 quarters · filed 2020-12-10 | |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $248.11K 10-Q · filed 2019-08-14 | $276.06K derived: sum of 3 quarters · filed 2020-12-10 | $276.06K derived: sum of 4 quarters · filed 2020-12-10 | |
| 2018-03-31 | $248.11K 10-Q · filed 2019-05-15 | $276.06K derived: sum of 2 quarters · filed 2020-12-10 | $276.06K derived: sum of 3 quarters · filed 2020-12-10 | $276.06K derived: sum of 4 quarters · filed 2020-12-10 | |
| 2017-12-31 | $27.95K derived: 8-K 12 month − 10-Q 9 month · filed 2020-12-10 | $27.95K derived: sum of 2 quarters · filed 2020-12-10 | $27.95K derived: sum of 3 quarters · filed 2020-12-10 | $27.95K 8-K · filed 2020-12-10 | |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | $0.00 derived: sum of 2 quarters · filed 2018-11-14 | $0.00 10-Q · filed 2018-11-14 | ||
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | $0.00 10-Q · filed 2018-08-14 | |||
| 2017-03-31 | $0.00 10-Q · filed 2018-05-09 | ||||
| 2016-12-31 | $0.00 10-K · filed 2019-03-12 | ||||
| 2015-12-31 | $0.00 10-K · filed 2018-03-09 | ||||
| 2009-12-31 | $7.48M 10-K · filed 2012-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |